Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
COLLINS, M. D., LAWSON, P. A., WILLEMS, A., CORDOBA, J. J., FERNANDEZ-GARAYZABAL, J., GARCIA, P., CAI, J., HIPPE, H., & FARROW, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,669
Cited by
Items 701–800 of 1,009
Yamada, S., Guo, X., & Tanimoto, A. (2018) · Pathology International · doi:10.1111/pin.12634 · Cited by 57
Dang, Y., Chen, J., Feng, W., Qiao, C., Han, W., Nie, Y., Wu, K., Fan, D., & Xia, L. (2020) · Theranostics · doi:10.7150/thno.41712 · Cited by 59
The microbiome(s) and cancer: know thy neighbor(s)
González‐Sánchez, P., & DeNicola, G. M. (2021) · The Journal of Pathology · doi:10.1002/path.5661 · Cited by 62
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症:英文版 · doi:10.1002/cac2.12182 · Cited by 64
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Temraz, S. N., Nassar, F. J., Kreidieh, F., Mukherji, D., Shamseddine, A. I., & Nasr, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157800 · Cited by 62
Cytoplasmic chromatin fragments-from mechanisms to therapeutic potential.
Miller, K. N., Dasgupta, N., Liu, T., Adams, P. D., & Vizioli, M. G. (2021) · eLife · doi:10.7554/elife.63728 · Cited by 55
“Approaches to reduce or alter the SASP have shown promise in animal models (Milanovic et al., 2018; Yoshimoto et al., 2013), suggesting that novel therapeutic targets could greatly advance this area”
BackgroundHealthy Gut, Healthy Bones: Targeting the Gut Microbiome to Promote Bone Health
Cooney, O. D., Nagareddy, P. R., Murphy, A. J., & Lee, M. K. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.620466 · Cited by 63
A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases
Adhikari, A. A., Ramachandran, D., Chaudhari, S. N., Powell, C. E., Li, W., McCurry, M. D., Banks, A. S., & Devlin, A. S. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00192 · Cited by 54
Yntema, T., Koonen, D. P. Y., & Kuipers, F. (2023) · Nutrients · doi:10.3390/nu15081850 · Cited by 59
Wang, Y., Li, Y., Lin, Y., Cao, C.-Y., Chen, D., Huang, X., Li, C., Xu, H., Lai, H., Chen, H., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02413-z · Cited by 70
Nakajima, T. (2015) · Medical Science Monitor · doi:10.12659/msm.893234 · Cited by 59
Tian, Y. T., Wang, H., Yuan, F., Li, N., Huang, Q., He, L., Wang, L., & Liu, Z. (2016) · BioMed Research International · doi:10.1155/2016/9462571 · Cited by 58
Caenorhabditis elegansas a model for cancer research
Kyriakakis, E., Markaki, M., & Tavernarakis, N. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975027 · Cited by 67
Ochi, T., Feng, Y., Kitamoto, S., Nagao‐Kitamoto, H., Kuffa, P., Atarashi, K., Honda, K., Teitelbaum, D. H., & Kamada, N. (2016) · Scientific Reports · doi:10.1038/srep27634 · Cited by 58
Self-citationHigher CYP2E1 Activity Correlates with Hepatocarcinogenesis Induced by Diethylnitrosamine
Gao, J., Wang, Z., Wang, G.-J., Zhang, H.-X., Gao, N., Wang, J., Wang, C., Chang, Z., Fang, Y., Zhang, Y., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245555 · Cited by 55
Promotion and induction of liver cancer by gut microbiome-mediated modulation of bile acids
Jia, B., & Jeon, C. O. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007954 · Cited by 57
Zhang, C., Liu, S., & Yang, M. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.808526 · Cited by 68
Achiwa, K., Ishigami, M., Ishizu, Y., Kuzuya, T., Honda, T., Hayashi, K., Hirooka, Y., Katano, Y., & Goto, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.012 · Cited by 54
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Mohseni, A. H., Taghinezhad‐S, S., Casolaro, V., Lv, Z., & Li, D. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05560-2 · Cited by 55
Fibroblasts as Turned Agents in Cancer Progression
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15072014 · Cited by 58
Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
Ohtani, N., Kamiya, T., & Kawada, N. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000241 · Cited by 64
Self-citationMarroncini, G., Naldi, L., Martinelli, S., & Amedei, A. (2024) · Biomedicines · doi:10.3390/biomedicines12071398 · Cited by 60
Yu, X., Wu, X., Qiu, L., Wang, D., Gan, M., Chen, X., Wei, H., & Xu, F. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6888-3 · Cited by 58
Markowitz, G. J., Yang, P., Fu, J., Michelotti, G. A., Chen, R., Sui, J., Yang, B., Qin, W., Zhang, Z., Wang, F., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1548 · Cited by 61
Absence of cytoglobin promotes multiple organ abnormalities in aged mice
Thủy, L. T. T., Thuy, T. T. V., Matsumoto, Y., Hai, H., Ikura, Y., Yoshizato, K., & Kawada, N. (2016) · Scientific Reports · doi:10.1038/srep24990 · Cited by 55
Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites
Fu, Z. D., & Cui, J. Y. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0087-0 · Cited by 56
Reciprocal interactions between bile acids and gut microbiota in human liver diseases
Ikegami, T., & Honda, A. (2018) · Hepatology Research · doi:10.1111/hepr.13001 · Cited by 55
Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest
Belužić, L., Grbeša, I., Belužić, R., Park, J. H., Kong, H. K., Kopjar, N., Espadas, G., Sabidó, E., Lepur, A., Rokić, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32356-8 · Cited by 61
Ogawa, Y., Kawakami, Y., & Tsubota, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116114 · Cited by 56
Wong, A. M., Ding, X., Wong, A. M. G., Xu, M., Zhang, L., Leung, H. H. W., Chan, A. W. H., Song, Q. X., Kwong, J., Chan, L. K., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.015 · Cited by 64
Huang, M., Ji, Q., Huang, H., Wang, X., & Wang, L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2486519 · Cited by 57
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
Kitabatake, H., Tanaka, N., Fujimori, N., Komatsu, M., Okubo, A., Kakegawa, K., Kimura, T., Sugiura, A., Yamazaki, T., Shibata, S., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i4.712 · Cited by 53
Genes, emotions and gut microbiota: The next frontier for the gastroenterologist
Panduro, A., Rivera‐Íñiguez, I., Sepúlveda-Villegas, M., & Román, S. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i17.3030 · Cited by 62
Characterisation of blood microbiota in patients with liver cirrhosis
Kajihara, M., Koido, S., Kanai, T., Ito, Z., Matsumoto, Y., Takakura, K., Saruta, M., Kato, K., Odamaki, T., Xiao, J., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001494 · Cited by 56
Ni, Y., Ni, L., Zhuge, F., & Fu, Z. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000375 · Cited by 57
Garber, K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3161 · Cited by 60
Okazaki, I., Noro, T., Tsutsui, N., Yamanouchi, E., Kuroda, H., Nakano, M., Yokomori, H., & Inagaki, Y. (2014) · Cancers · doi:10.3390/cancers6031220 · Cited by 61
Schinzari, V., Barnaba, V., & Piconese, S. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.026 · Cited by 57
Obesity and the gut microbiome: pathophysiological aspects
Bradlow, H. L. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0063 · Cited by 52
Kong, M., Liu, H., Wu, J., Shen, M., Wang, Z., Duan, S.-M., Zhang, Y., Zhu, H., & Li, S. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.10.023 · Cited by 52
The role of gut microbiota in liver disease development and treatment
Wang, L., & Wan, Y. Y. (2019) · Liver Research · doi:10.1016/j.livres.2019.02.001 · Cited by 58
Ohtani, N. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz055 · Cited by 57
Self-citationAssessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma
Puttalingaiah, R. T., Roy, S. K., Shrivastava, A., LaVeist, T. A., Shankar, S., & Srivastava, R. K. (2020) · JGH Open · doi:10.1002/jgh3.12336 · Cited by 56
Association between 12α-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet
Hori, S., Abe, T., Lee, D. G., Fukiya, S., Yokota, A., Aso, N., Shirouchi, B., Satô, M., & Ishizuka, S. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108412 · Cited by 56
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 61
p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities
Tan, C. T., Soh, N. J. H., Chang, H., & Yu, V. C. K. (2021) · FEBS Journal · doi:10.1111/febs.16317 · Cited by 56
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Rosean, C. B., Feng, T.-Y., Azar, F. N., & Rutkowski, M. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.005 · Cited by 55
Mima, K., Kosumi, K., Baba, Y., Hamada, T., Baba, H., & Ogino, S. (2020) · Human Genetics · doi:10.1007/s00439-020-02235-2 · Cited by 53
Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
Li, L., Liu, T., Gu, Y., Wang, X., Xie, R., Sun, Y., Wang, B., & Cao, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974305 · Cited by 57
Zhao, D., Gao, Y., Su, Y., Zhou, Y., Yang, T., Yang, L., Wang, Y., Sun, Y., Chen, L., Zhang, F., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106590 · Cited by 54
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 57
Modulation of p53 during bacterial infections
Siegl, C., & Rudel, T. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3537 · Cited by 57
Xiong, F., Wu, S., Zhang, J., Jakovlić, I., Li, W.-X., Zou, H., Li, M., & Wang, G.-T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02209 · Cited by 54
Tanaka, M., Sanefuji, M., Morokuma, S., Yoden, M., Momoda, R., Sonomoto, K., Ogawa, M., Kato, K., & Nakayama, J. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1650997 · Cited by 51
Oral microbial community analysis of the patients in the progression of liver cancer
Li, D., Xi, W., Zhang, Z., Ren, L., Deng, C., Chen, J., Sun, C., Zhang, N., & Xu, J. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104479 · Cited by 54
Silver, D. J., Roversi, G. A., Bithi, N., Wang, S. Z., Troike, K. M., Neumann, C. K. A., Ahuja, G. K., Reizes, O., Brown, J. M., Hine, C., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138276 · Cited by 55
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
New aspects of IgA synthesis in the gut
Suzuki, K., & Nakajima, A. (2014) · International Immunology · doi:10.1093/intimm/dxu059 · Cited by 57
Burmeister, D. M., Johnson, T. R., Lai, Z., Sayyadioskoie, S., DeRosa, M., Jonas, R. B., Zhu, C. S., Scherer, E., Stewart, R. M., Schwacha, M. G., et al. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002612 · Cited by 50
Implications of Gut Microbiota in Complex Human Diseases
Yu, D., Meng, X., de Vos, W. M., Wu, H., Fang, X., & Maiti, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312661 · Cited by 56
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
Song, Y., Lau, H. C.-H., Zhang, X., & Yu, J. Q. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0394 · Cited by 79
Samy, A. M., Kandeil, M. A., Sabry, D., Abdel-Ghany, A. A., & Mahmoud, M. O. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30387 · Cited by 60
Metabolites from intestinal microbes shape Treg
Geuking, M. B., McCoy, K. D., & Macpherson, A. J. (2013) · Cell Research · doi:10.1038/cr.2013.125 · Cited by 54
Bhowmik, S., Chiu, H., Jones, D. H., Chiu, H., Miller, M. D., Xu, Q., Farr, C. L., Ridlon, J. M., Wells, J. E., Elsliger, M., et al. (2016) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.24971 · Cited by 50
Rethinking the bile acid/gut microbiome axis in cancer
Phelan, J. P., Reen, F. J., Caparros-Martin, J. A., O’Connor, R., & O’Gara, F. (2017) · Oncotarget · doi:10.18632/oncotarget.22803 · Cited by 56
Gerritsen, J., Umanets, A., Staneva, I., Hornung, B., Ritari, J., Paulin, L. G., Rijkers, G. T., de Vos, W. M., & Smidt, H. (2018) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.003012 · Cited by 50
Fibroblasts in liver cancer: functions and therapeutic translation
Affo, S., Filliol, A., Gores, G. J., & Schwabe, R. F. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00111-5 · Cited by 49
Bile acid metabolism in health and ageing-related diseases
Li, X., Fang, C., Zhao, R., Zou, L., Miao, H., & Zhao, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116313 · Cited by 60
Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease
Wang, Y., Bai, M., Peng, Q., Li, L., Tian, F., Guo, Y., & Jing, C. (2024) · European journal of medical research · doi:10.1186/s40001-024-02224-5 · Cited by 55
Yamada, S., Kamada, N., Amiya, T., Nakamoto, N., Nakaoka, T., Kimura, M., Saito, Y., Ejima, C., Kanai∥, T., & Saito, H. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0689-3 · Cited by 53
Kainuma, M., Takada, I., Makishima, M., & Sano, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071898 · Cited by 52
Ishii, C., Nakanishi, Y., Murakami, S., Nozu, R., Ueno, M., Hioki, K., Aw, W., Hirayama, A., Soga, T., Ito, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124079 · Cited by 56
Udden, S. M. N., Kwak, Y.-T., Godfrey, V., Khan, M. A. W., Khan, S., Loof, N., Peng, L., Zhu, H., & Zaki, H. (2019) · eLife · doi:10.7554/elife.40396 · Cited by 54
Liu, P., Tang, Q., Chen, M., Chen, W., Lu, Y., Liu, Z., & He, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589908 · Cited by 56
G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment
Yang, M. J., & Zhang, C.-Y. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i8.677 · Cited by 51
Aw, W., & Fukuda, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0456-2 · Cited by 57
Ren, Z., Cui, G., Lu, H., Chen, X., Jiang, J., Liu, H., He, Y., Ding, S., Hu, Z., Wang, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075950 · Cited by 52
Commensal bacteria modulate the tumor microenvironment
Poutahidis, T., & Erdman, S. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.028 · Cited by 55
Lee, J. S., Yoo, J. E., Kim, H., Rhee, H., Koh, M. J., Nahm, J. H., Choi, J. S., Lee, K.-H., & Park, Y. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171922 · Cited by 53
Ma, C., Zhang, Q., & Greten, T. F. (2017) · FEBS Journal · doi:10.1111/febs.14209 · Cited by 54
Uni, M., Masamoto, Y., Sato, T., Kamikubo, Y., Arai, S., Hara, E., & Kurokawa, M. (2018) · Leukemia · doi:10.1038/s41375-018-0198-6 · Cited by 55
Self-citationMcCarthy, C. G., Wenceslau, C. F., Webb, R. C., & Joe, B. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz052 · Cited by 50
González-Meljem, J. M., & Martínez-Barberá, J. P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03798-7 · Cited by 54
Crosstalk between gut microbiota and cellular senescence: a vicious cycle leading to aging gut
Kawamoto, S., & Hara, E. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.12.004 · Cited by 49
Self-citationGut microbial metabolites in cancer immunomodulation
Liu, H., Xiong, X., Zhu, W., Wang, S., Huang, W.-C., Zhu, G., Xu, H., & Yang, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02521-5 · Cited by 62
Molecular mechanisms of ageing and related diseases
Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12247 · Cited by 56
Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
Ip, B. C., & Wang, X. (2013) · Nutrients · doi:10.3390/nu6010124 · Cited by 52
Song, M., & Chan, A. T. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0389-y · Cited by 57
Chu, J., Vila‐Farrés, X., & Brady, S. F. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b07317 · Cited by 51
Pocha, C., & Xie, C. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.09.01 · Cited by 50
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Raza, S., Rajak, S., Anjum, B., & Sinha, R. A. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2019.014 · Cited by 54
Yamane, M., Sato, S., Shimizu, E., Shibata, S., Hayano, M., Yaguchi, T., Kamijuku, H., Ogawa, M., Suzuki, T., Mukai, S., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201900218r · Cited by 51
Self-citationImplications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Javed, I., Cui, X., Wang, X., Mortimer, M., Andrikopoulos, N. K., Li, Y., Davis, T. P., Zhao, Y., Ke, P. C., & Chen, C. (2020) · ACS Nano · doi:10.1021/acsnano.0c07258 · Cited by 48
Shi, Z., Chen, G., Cao, Z., Wu, F., Lei, H., Chen, C., Song, Y., Liu, C., Li, J., Zhou, J., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07467 · Cited by 47
Ji, G., Si, X., Dong, S., Xu, Y., Li, M., Yang, B., Tang, Z., Fang, X., Huang, L., Song, W., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01360 · Cited by 46
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 70
Microbiota in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Guan, D., Wang, Z., Li, X., Dong, S., Huang, J., & Zhou, W. (2023) · MedComm · doi:10.1002/mco2.417 · Cited by 50
Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis
Sheng, D., Jin, C., Yue, K., Yue, M., Liang, Y., Xue, X., Li, P., Zhao, G., & Zhang, L. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217077 · Cited by 48
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
Jiang, C., Pu, C., Hou, Y., Chen, Z., Alanazy, M. H., & Hebbard, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16464 · Cited by 51
All-trans retinoic acid regulates hepatic bile acid homeostasis
Yang, F., He, Y., Liu, H., Tsuei, J., Jiang, X., Yang, L., Wang, Z., & Wan, Y. Y. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.018 · Cited by 48
Metadata
- Authors
- Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., Honda, K., Ishikawa, Y., Hara, E., & Ohtani, N.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokyo University of Science (JP)
- Japan Science and Technology Agency (JP)
- Tokushima University (JP)
- The University of Tokyo (JP)
- Azabu University (JP)
- Corresponding author
- Hara, Eiji
- ORCID
- Venue
- Nature
- Published
- 2013-06-26
- Volume
- 499
- Issue
- 7456
- Pages
- 97-101
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132406938
- Cited by
- 2,219
- References
- 40
- Citations by year
- 2026: 131 · 2025: 164 · 2024: 175 · 2023: 196 · 2022: 208 · 2021: 224 · 2020: 198 · 2019: 175 · 2018: 172 · 2017: 142 · 2016: 130 · 2015: 125 · 2014: 125 · 2013: 47
- FWCI
- 63.80
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-29)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (23300343, 221S0001, 24650625, 23300352, 25293080)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obesity, hepatocellular carcinoma, senescence-associated secretory phenotype, deoxycholic acid, gut microbiota, hepatic stellate cells, high-fat diet, bile acid metabolism, DNA damage, carcinogenesis, antibiotic intervention, chemical carcinogens, inflammation, obesity-related cancer, therapeutic target, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bile Acids and Salts, Cells, Cultured, Deoxycholic Acid, Dietary Fats, Disease Models, Animal, DNA Damage, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Phenotype, Risk Factors, Cytokines, Cellular Senescence, Gastrointestinal Tract, Mice, Interleukin-1beta, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.